<DOC>
	<DOCNO>NCT00802685</DOCNO>
	<brief_summary>The investigator propose present study follow aim : - determine whether early patent ductus arteriosus ( PDA ) treatment ibuprofen treatment onset clinical symptom superior late ibuprofen treatment symptom hemodynamically significant PDA present evolution bronchopulmonary dysplasia ( BPD ) define duration supplemental oxygen exposure first 28 day - determine whether early PDA treatment ibuprofen superior late treatment ibuprofen efficacy PDA closure , need rescue therapy , need PDA ligation incidence major complication prematurity . Hypothesis : Early pharmacologic closure PDA ibuprofen improve respiratory course reduce BPD reflect reduction duration supplemental oxygen first 28 day age vs. late pharmacologic treatment ibuprofen . Outcome variable : The primary outcome study number day spend supplemental oxygen infant first 28 day . Other outcome determine group include : - Mortality - Other respiratory variable : total day supplemental oxygen , day mechanical ventilation , oxygen dependence 36 week post menstrual age , age final extubation . - Other respiratory complication : pneumothorax , pulmonary interstitial emphysema , need high frequency ventilation , pulmonary hypertension - Efficacy PDA closure : number course medication require , need ligation - Other neonatal complication : intraventricular hemorrhage ( IVH ) , periventricular leukomalacia ( PVL ) , retinopathy prematurity ( ROP ) , necrotizing enterocolitis ( NEC ) , intestinal perforation , sepsis , renal dysfunction ( oliguria , elevated creatinine ) - Time achieve full enteral feeding , time regain birth weight , weight discharge . - Length hospital stay</brief_summary>
	<brief_title>Timing PDA Closure Respiratory Outcome Premature Infants</brief_title>
	<detailed_description>Study terminate intravenous ( IV ) ibuprofen withdrawn clinical research use .</detailed_description>
	<mesh_term>Ductus Arteriosus , Patent</mesh_term>
	<mesh_term>Polystyrene sulfonic acid</mesh_term>
	<mesh_term>Ibuprofen</mesh_term>
	<criteria>Inborn patient JHS hospital ( admit NICU JMH within first 72 hr age BW 5001250 gram 2332 wks gestational age &gt; 1d &lt; 14d age . Major congenital malformation Proven sepsis ( positive blood culture ) Contraindications use Ibuprofen Indomethacin Terminal condition , expect survive beyond 48 h Infants bear excessively SGA ( 3 S.D . mean GA ) Infants initial PDA presentation hemodynamically significant</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>14 Days</maximum_age>
	<verification_date>December 2013</verification_date>
	<keyword>Patent ductus arteriosus</keyword>
	<keyword>Respiratory outcome</keyword>
</DOC>